Table 2.
Score | Baseline | Post-Surgery Discharge |
Long-Term Follow-Up |
---|---|---|---|
Rankin 0–1 | 14 (20%) | 30 (45%) | 39 (58%) |
Rankin 2 | 30 (45%) | 20 (30%) | 16 (24%) |
Rankin 3 | 16 (25%) | 12 (18%) | 7 (10%) |
Rankin 4 | 7 (10%) | 5 (7%) | 2 (3%) |
Rankin 5 | 0 | 0 | 1 (2%) |
Death | 0 | 0 | 2 (3%)* |
One patient had decline in mRS due to comorbidities unrelated to moyamoya disease progression